vs
Cytosorbents Corp（CTSO）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Cytosorbents Corp的季度营收约是Rocky Mountain Chocolate Factory, Inc.的1.2倍（$9.2M vs $7.5M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -59.5%，领先57.5%），Cytosorbents Corp同比增速更快（0.9% vs -4.4%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-4.9M），过去两年Rocky Mountain Chocolate Factory, Inc.的营收复合增速更高（1.9% vs 1.3%）
Cytosorbents是一家公开上市企业，总部位于美国新泽西州普林斯顿，专注于血液净化领域相关医疗产品的研发与商业化，核心产品应用于重症救治场景，帮助去除患者血液中的炎性介质等有害物质。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
CTSO vs RMCF — 直观对比
营收规模更大
CTSO
是对方的1.2倍
$7.5M
营收增速更快
CTSO
高出5.3%
-4.4%
净利率更高
RMCF
高出57.5%
-59.5%
自由现金流更多
RMCF
多$3.7M
$-4.9M
两年增速更快
RMCF
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $7.5M |
| 净利润 | $-5.5M | $-155.0K |
| 毛利率 | 73.7% | 34.0% |
| 营业利润率 | -47.5% | 1.1% |
| 净利率 | -59.5% | -2.1% |
| 营收同比 | 0.9% | -4.4% |
| 净利润同比 | 27.4% | 81.7% |
| 每股收益（稀释后） | $-0.09 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTSORMCF
| Q4 25 | $9.2M | $7.5M | ||
| Q3 25 | $9.5M | $6.8M | ||
| Q2 25 | $9.6M | $6.4M | ||
| Q1 25 | $8.7M | $8.9M | ||
| Q4 24 | $9.2M | $7.9M | ||
| Q3 24 | $8.6M | $6.4M | ||
| Q2 24 | $8.8M | $6.4M | ||
| Q1 24 | $9.0M | $7.3M |
净利润CTSORMCF
| Q4 25 | $-5.5M | $-155.0K | ||
| Q3 25 | $-3.2M | $-662.0K | ||
| Q2 25 | $1.9M | $-324.0K | ||
| Q1 25 | $-1.5M | $-2.9M | ||
| Q4 24 | $-7.6M | $-847.0K | ||
| Q3 24 | $-2.8M | $-722.0K | ||
| Q2 24 | $-4.3M | $-1.7M | ||
| Q1 24 | $-6.1M | $-1.6M |
毛利率CTSORMCF
| Q4 25 | 73.7% | 34.0% | ||
| Q3 25 | 70.3% | 23.6% | ||
| Q2 25 | 70.9% | 31.1% | ||
| Q1 25 | 71.1% | 10.8% | ||
| Q4 24 | 68.4% | 23.4% | ||
| Q3 24 | 61.0% | 31.8% | ||
| Q2 24 | 73.5% | 12.8% | ||
| Q1 24 | 76.5% | 24.3% |
营业利润率CTSORMCF
| Q4 25 | -47.5% | 1.1% | ||
| Q3 25 | -30.2% | -7.0% | ||
| Q2 25 | -37.6% | -2.3% | ||
| Q1 25 | -44.5% | -30.3% | ||
| Q4 24 | -37.1% | -8.9% | ||
| Q3 24 | -56.1% | -14.3% | ||
| Q2 24 | -40.4% | -25.4% | ||
| Q1 24 | -51.8% | -21.7% |
净利率CTSORMCF
| Q4 25 | -59.5% | -2.1% | ||
| Q3 25 | -33.4% | -9.7% | ||
| Q2 25 | 20.2% | -5.1% | ||
| Q1 25 | -16.9% | -32.5% | ||
| Q4 24 | -82.7% | -10.7% | ||
| Q3 24 | -32.1% | -11.3% | ||
| Q2 24 | -48.6% | -25.9% | ||
| Q1 24 | -67.7% | -21.9% |
每股收益（稀释后）CTSORMCF
| Q4 25 | $-0.09 | $-0.02 | ||
| Q3 25 | $-0.05 | $-0.09 | ||
| Q2 25 | $0.03 | $-0.04 | ||
| Q1 25 | $-0.02 | $-0.38 | ||
| Q4 24 | $-0.14 | $-0.11 | ||
| Q3 24 | $-0.05 | $-0.11 | ||
| Q2 24 | $-0.08 | $-0.26 | ||
| Q1 24 | $-0.11 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.2M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.9M | $6.0M |
| 总资产 | $44.2M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTSORMCF
| Q4 25 | $6.2M | $641.0K | ||
| Q3 25 | $7.5M | $2.0M | ||
| Q2 25 | $10.2M | $893.0K | ||
| Q1 25 | $11.6M | $720.0K | ||
| Q4 24 | $3.3M | $1.1M | ||
| Q3 24 | $5.7M | $973.0K | ||
| Q2 24 | $8.5M | $637.0K | ||
| Q1 24 | $8.6M | $2.1M |
总债务CTSORMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $4.4M | — |
股东权益CTSORMCF
| Q4 25 | $5.9M | $6.0M | ||
| Q3 25 | $9.0M | $6.1M | ||
| Q2 25 | $11.6M | $6.7M | ||
| Q1 25 | $14.5M | $7.0M | ||
| Q4 24 | $11.1M | $9.8M | ||
| Q3 24 | $13.4M | $10.5M | ||
| Q2 24 | $17.4M | $9.0M | ||
| Q1 24 | $19.6M | $10.6M |
总资产CTSORMCF
| Q4 25 | $44.2M | $20.7M | ||
| Q3 25 | $45.8M | $22.3M | ||
| Q2 25 | $48.0M | $20.1M | ||
| Q1 25 | $50.8M | $21.2M | ||
| Q4 24 | $47.4M | $21.6M | ||
| Q3 24 | $47.8M | $21.1M | ||
| Q2 24 | $53.4M | $19.0M | ||
| Q1 24 | $47.1M | $20.6M |
负债/权益比CTSORMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.8M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.9M | $-1.3M |
| 自由现金流率自由现金流/营收 | -53.4% | -16.9% |
| 资本支出强度资本支出/营收 | 1.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.5M | — |
8季度趋势，按日历期对齐
经营现金流CTSORMCF
| Q4 25 | $-4.8M | $-1.2M | ||
| Q3 25 | $-2.6M | $-488.0K | ||
| Q2 25 | $-1.5M | $350.0K | ||
| Q1 25 | $-3.5M | $1.2M | ||
| Q4 24 | $-2.3M | $-2.1M | ||
| Q3 24 | $-2.5M | $-3.5M | ||
| Q2 24 | $-4.8M | $-2.2M | ||
| Q1 24 | $-4.8M | $129.0K |
自由现金流CTSORMCF
| Q4 25 | $-4.9M | $-1.3M | ||
| Q3 25 | $-2.6M | $-544.0K | ||
| Q2 25 | $-1.5M | $182.0K | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-2.4M | — | ||
| Q3 24 | $-2.6M | $-4.6M | ||
| Q2 24 | $-4.8M | $-2.6M | ||
| Q1 24 | $-4.9M | $-352.3K |
自由现金流率CTSORMCF
| Q4 25 | -53.4% | -16.9% | ||
| Q3 25 | -27.3% | -8.0% | ||
| Q2 25 | -16.1% | 2.9% | ||
| Q1 25 | -39.7% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -30.4% | -72.6% | ||
| Q2 24 | -54.4% | -40.2% | ||
| Q1 24 | -54.2% | -4.9% |
资本支出强度CTSORMCF
| Q4 25 | 1.2% | 0.5% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.4% | 2.6% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.8% | 17.5% | ||
| Q2 24 | 0.2% | 6.5% | ||
| Q1 24 | 0.5% | 6.6% |
现金转化率CTSORMCF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.78× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
